Metabolic Disease Trials

Metabolic conditions include type 2 diabetes, obesity, dyslipidaemia, and related endocrine pathologies. The final sample included 444 industry-sponsored phase 1-3 metabolic disease trials. Eligible metabolic disease trials focused on diabetes, obesity, and dyslipidaemia. The study falls under the Diabetes and Endocrinology subject area. The study focused on metabolic diseases because DCTs are common in this area and trial designs are relatively standardised. The disease focus of the underlying study was metabolic conditions. Metabolic diseases are suited to remote physiological monitoring such as blood glucose monitoring and wearable data collection.